Medicines from microbiota
B Olle - Nature biotechnology, 2013 - nature.com
B Olle
Nature biotechnology, 2013•nature.comFive years after the launch of the Human Microbiome Project, several ventures are seeking
to capitalize on the clinical promise of microbiome modulation. Commercialization of drugs
that influence the human flora poses some unique scientific, translational and regulatory
challenges.
to capitalize on the clinical promise of microbiome modulation. Commercialization of drugs
that influence the human flora poses some unique scientific, translational and regulatory
challenges.
Five years after the launch of the Human Microbiome Project, several ventures are seeking to capitalize on the clinical promise of microbiome modulation. Commercialization of drugs that influence the human flora poses some unique scientific, translational and regulatory challenges.
nature.com